title: Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.
abstract: Erythropoietin (Epo) and its receptor (EpoR) are indispensable to erythropoiesis. Although roles besides angiogenesis, such as neuroprotection and heart development, have been reported for the Epo-EpoR system, the precise contribution of Epo-EpoR to these nonhematopoietic tissues requires clarification. Exploiting a GATA-1 minigene cassette with hematopoietic regulatory domains, we established 2 lines of transgene-rescued EpoR-null mutant mice expressing EpoR exclusively in the hematopoietic lineage. Surprisingly, despite the lack of EpoR expression in nonhematopoietic tissues, these mice develop normally and are fertile. As such, we could exploit them for analyzing the roles of the Epo-EpoR system in adult hematopoiesis and in nonhematopoietic tissues. These rescued lines showed a differential level of EpoR expression in erythroid cells; one expressed approximately 40%, and the other expressed 120% of the wild-type EpoR level. A colony formation assay showed that erythroid progenitors in the 2 mutant lines exhibit distinct sensitivity to Epo. The circulating Epo level was much higher in the transgenic line with a lower EpoR expression. In response to induced anemia, the plasma Epo concentrations increased in both lines. Notably, the timing of the peak of plasma Epo concentration was delayed in both lines of rescued mice compared with wild type, suggesting that, in wild-type mice, nonhematopoietic EpoR contributes to the regulation of plasma Epo concentration. We thus conclude that nonhematopoietic expression of EpoR is dispensable to normal mouse development and that the expression level of EpoR regulates erythropoiesis by controlling the sensitivity of erythroid progenitors to Epo.
authors.affiliation: Center for Tsukuba Advanced Research Alliance, Institutes of Basic Medical Sciences and Clinical Medicine, University of Tsukuba, Tokyo, Japan.
authors.forename: Norio
authors.initials: N
authors.lastname: Suzuki
authors.forename: Osamu
authors.initials: O
authors.lastname: Ohneda
authors.forename: Satoru
authors.initials: S
authors.lastname: Takahashi
authors.forename: Masato
authors.initials: M
authors.lastname: Higuchi
authors.forename: Harumi Y
authors.initials: HY
authors.lastname: Mukai
authors.forename: Tatsutoshi
authors.initials: T
authors.lastname: Nakahata
authors.forename: Shigehiko
authors.initials: S
authors.lastname: Imagawa
authors.forename: Masayuki
authors.initials: M
authors.lastname: Yamamoto
mesh_terms: D000740:Anemia / Q000235:genetics / Q000473:pathology / Q000628:therapy; D000818:Animals; D017209:Apoptosis; D017931:DNA Primers; D005314:Embryonic and Fetal Development; D005260:Female; D005313:Fetal Death; D005804:Genes, Lethal; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000473:pathology / Q000502:physiology*; D020287:In Situ Nick-End Labeling; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D017467:Receptors, Erythropoietin / Q000172:deficiency / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D017467:Receptors, Erythropoietin